ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

First Chop Awards Made, 17 Others In Negotiation For NCI Program To Upgrade Community Cancer Care

October 24, 1980

Cell Culture ID Offered By NIC

January 7, 1983

Hearing Probes CDC On Cancer Treatment For Working Poor In Screening Program

July 23, 1999

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

ICF Clement Joins Dynalectron In FCRF

January 9, 1987

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 12, 1974